Request to Join
has invited you to join this group
uBiome is the world’s leading microbial genomics company with a mission to advance the science of the microbiome and make useful products to improve human life.
The human microbiome consists of microorganisms living in the gut, skin, and in many areas of the body.. With the availability of rapid sequencing technology, it is now easier than ever to detect, quantify, and monitor patterns in the microbiota at multiple time periods. Now is one of the most exciting times in microbiome research with over 1,100 registered clinical trials.
Since its inception in 2012, uBiome has partnered with hundreds of academic centers and over 1,000 researchers worldwide to conduct important microbiome research. Now, with the availability of clinical microbiome tests such as SmartGut and SmartJane, uBiome is making a call for research partners in the clinical space to expand clinical outcomes data in microbiome research and bring that knowledge to the bedside.
Our clinical research partners also use our Precision Sequencing™ technology, in our CLIA certified and CAP accredited laboratory.
uBiome aims to support selected microbiome-related clinical research ideas and proposals and provide in-kind research logistics and laboratory services. This is an ongoing initiative with rolling submissions and reviews. Entries are judged by our Medical Affairs, Research and Development, and Executive teams.
All eligible microbiome-related submissions will be accepted for review, but areas of emphasis include those using SmartGut (stool) and/or SmartJane (vaginal) kits as part of a study to impact costly and burdensome clinical areas for our healthcare system.
uBiome seeks to evolve available microbiome data such that microbiota can better guide clinicians through diagnosis and therapy—from wellness to illness to treatment and beyond—allowing clinicians to better focus on patient function, state, outcomes, and goals. We believe in the power of citizen science, as well as the scientific community, to help answer some of medicine’s biggest questions. This challenge creates a medical community to discuss some of these issues collaboratively. It allows clinicians to join teams, develop collaborations, and show the public that medicine is serious about microbiome research.
Genomics research may seem daunting to even the most seasoned clinician. The Microbiome Innovation Challenge, however, encourages the medical community, regardless of research expertise, to submit ideas and research questions about the microbiome.
The Challenge seeks to:
This Challenge is an open clinical call for ideas and proposals that investigate a novel clinical use of microbiome testing. A number of burdensome chronic conditions across multiple organ systems (e.g. IBS, IBD, Parkinson’s, infertility, depression, rosacea, etc.) are linked to changes or an imbalance in the microbiome. With the availability of affordable at-home testing, the challenge brings together clinicians from all over the world to investigate clinical applications of microbiome science.
Entrants are asked to submit ideas that demonstrate how and when microbiome data are collected, what changes are expected, and (where possible) how this may become a therapeutic target in the future.
Although there are many human ecosystems of microbiota, this particular Challenge is focused on clinical use of gut microbiome (stool) samples using SmartGut and vaginal microbiome (vaginal swab) samples using SmartJane. If you wish to sample a different part of the body, please contact us.
uBiome’s precision sequencing™ technology includes 16s and full shotgun metagenomic sequencing.
You (and your patient) will receive the clinical reports on our portal. If you do not wish for your patient to receive clinical reports during your study, please notify us in advance at email@example.com. You may also access the raw data in CSV, JSON and FASTQ formats. Please note in your submission whether you require assistance with data analysis.
Entrants are asked to present ideas on clinical applications of microbiome testing in one or more phases of a disease process or state of health. Examples of types of clinical applications:
Entry is open to clinicians and healthcare providers worldwide who are licensed and legally able to order laboratory tests in their state or country. Unlicensed trainees such as medical students and residents may submit if a licensed faculty sponsor is listed in the application.
The following are not eligible to enter the Challenge if, during the Challenge, they were or become:
To enter, complete all fields on the Official Entry Form on the website. Each entry should include any supporting material, including diagrams, videos, drawings, etc. Entry is only available online. Submissions in person, by mail, or other means will not be accepted. Each entry must be received during the Challenge entry period and must include the following:
The maximum size of uploaded files is as follows:
There are no entry fees. If you are selected and choose to enter into a research collaboration with uBiome, you may incur costs related to participating in a research study at your location such as IRB fees or other standard costs. Depending on the complexity of the study, there may be other fees.
Winners will receive in-kind laboratory services, including sample kits and sequencing. Some winners may also receive additional services such as study design and analysis.
Planned completion date
September 15, 2018
Challenge Entry Period starts
September 15, 2018
Challenge Entry Period ends
September 15, 2019
You are welcome to ask your friends and family to vote for your entry during crowdsource voting. An individual can vote once in crowdsource voting. Multiple votes by the same person, votes using fraudulent or false social media profiles, votes by bots or other automated means or any other fraudulent activity can be grounds for disqualification.
Yes. The Challenge administrator will publicly post crowdsource voting totals for the public to see.
No, votes by Challenge judges will not be posted.
The public will be invited to vote and comment on each entry. Unless a comment is deemed by the Challenge administrator to be offensive or in poor taste, public comments will be posted.
The administrator intends to post entries on a first-come, first-served basis. The Challenge administrator plans to post each Entry a minimum of two weeks on the Challenge website.
The Challenge administrator (uBiome) will (1) post each qualified Entry on the Challenge website for crowdsource voting and comment and (2) submit the Entry for voting by the Challenge Judges.
The judges will be selected by uBiome and will include members of the Medical Affairs, Scientific Editorial, and Research & Development teams..
No. Entrants will continue to own the IP rights to their entries. uBiome only asks that Entrants give uBiome a worldwide, perpetual, non-revocable license to post the Qualified Entry on the Challenge website.
At the Challenge administrator’s discretion, an Entry whose ownership is claimed by a third party may be (a) disqualified; (b) allowed to compete or (c) held in suspension while the Challenge administrator considers the matter.
Each Entrant’s consent to posting of an entry is a condition of entry to the Challenge. If you don’t want your entry to be published on the Challenge website, you should withdraw your entry before it is posted.